Search hospitals > Quebec > MONTREAL
Maisonneuve-Rosemont Hospital
Claim this profileMONTREAL, Quebec H1T 2M4
Global Leader in Breast Cancer
Global Leader in Acute Myelogenous Leukemia
Conducts research for Leukemia
Conducts research for Acute Myeloid Leukemia
Conducts research for Cancer
317 reported clinical trials
26 medical researchers
Summary
Maisonneuve-Rosemont Hospital is a medical facility located in MONTREAL, Quebec. This center is recognized for care of Breast Cancer, Acute Myelogenous Leukemia, Leukemia, Acute Myeloid Leukemia, Cancer and other specialties. Maisonneuve-Rosemont Hospital is involved with conducting 317 clinical trials across 475 conditions. There are 26 research doctors associated with this hospital, such as Michael Yassa, Jonathan Noujaim, Dr. Mai-Kim Gervais, and Veronique Brulotte, MD, MSc.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
HER2 positive
2Acute Myelogenous Leukemia
Global LeaderNPM1-m positive
CD33 positive
KMT2A positive
Top PIs
Michael YassaMaisonneuve-Rosemont Hospital2 years of reported clinical research
Studies Breast Cancer
Studies Postmastectomy Lymphedema Syndrome
6 reported clinical trials
8 drugs studied
Jonathan NoujaimGSK Investigational Site2 years of reported clinical research
Studies Cancer
Studies Tumors
5 reported clinical trials
13 drugs studied
Dr. Mai-Kim GervaisHopital Maisonneuve Rosemont4 years of reported clinical research
Studies Retroperitoneal Sarcoma
Studies Leiomyosarcoma
3 reported clinical trials
5 drugs studied
Veronique Brulotte, MD, MScMaisonneuve-Rosemont Hospital11 years of reported clinical research
Studies Chronic Pain
Studies Cytokines
3 reported clinical trials
3 drugs studied
Clinical Trials running at Maisonneuve-Rosemont Hospital
Prostate Cancer
Breast Cancer
Acute Myeloid Leukemia
Acute Myelogenous Leukemia
Acute Lymphoblastic Leukemia
Cancer
Acute Leukemia
Chronic Renal Failure
Cardiovascular Disease
Colorectal Cancer
Darolutamide + SBRT
for Prostate Cancer
This trial tests a combination of precise radiation therapy and a hormone-blocking drug in prostate cancer patients with limited spread. It aims to control the disease and delay more toxic treatments. The approach targets small areas of cancer spread and blocks the cancer's growth signals. The hormone-blocking drug is a novel treatment approved for specific prostate cancer cases.
Recruiting2 awards Phase 23 criteria
Docetaxel + Hormone Therapy
for Prostate Cancer
This study is being done to answer the following question: can the chance of prostate cancer growing or spreading be lowered by adding a drug to the usual combination of drugs? This study would like to find out if this approach is better or worse than the usual approach for prostate cancer. The usual approach for patients who are not in a study is hormone treatment with Androgen Deprivation Therapy (ADT) and Androgen-Receptor Pathway Inhibitor (ARPI).
Recruiting2 awards Phase 35 criteria
Shorter vs Usual Radiation Therapy
for Prostate Cancer
This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period of time. This trial is evaluating if shorter duration radiation prevents cancer from coming back as well as the usual radiation treatment.
Recruiting2 awards Phase 310 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Maisonneuve-Rosemont Hospital?
Maisonneuve-Rosemont Hospital is a medical facility located in MONTREAL, Quebec. This center is recognized for care of Breast Cancer, Acute Myelogenous Leukemia, Leukemia, Acute Myeloid Leukemia, Cancer and other specialties. Maisonneuve-Rosemont Hospital is involved with conducting 317 clinical trials across 475 conditions. There are 26 research doctors associated with this hospital, such as Michael Yassa, Jonathan Noujaim, Dr. Mai-Kim Gervais, and Veronique Brulotte, MD, MSc.
Where is Maisonneuve-Rosemont Hospital located?
**Maisonneuve-Rosemont Hospital**
- **Address:** 5415 Boulevard de l'Assomption, Montreal, Quebec.
- **Accessibility:** The hospital is about a 13-minute walk from Station Viau, the nearest metro station.
Who should I call to ask about financial aid or insurance network?
**Maisonneuve-Rosemont Hospital Financial and Insurance Services**
**Financial Services:**
- CIUSSS EMTL - Exclusifs benefits - Financial services - Beneva
**Insurance and Financial Services:**
- Agency: Montréal Maisonneuve, iA Financial Group
- Location: 6555 Métropolitain Blvd. E, Unit 403, Saint-Léonard, Quebec, H1P 3H3
- Contact: 514-324-3811, Toll-free: 1-866-324-3811, Fax: 1-877-781-7413
- Hours: Mon-Fri, 8:30 am - 4:30 pm
**Public Health Insurance and Prescription Drug Insurance Plans:**
- Provider: Régie de l'assurance maladie du Québec (RAMQ)
- Contact: Québec: 418 646-4636, Montréal: 514 864-3411, Toll-free: 1 800 561-9749, Outside Québec: 514 864-3411
- Hours: Mon-Fri, 8:30 am - 4:30 pm
What insurance does Maisonneuve-Rosemont Hospital accept?
Maisonneuve-Rosemont Hospital is part of the Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l’Est-de-l’Île-de-Montréal. It is affiliated with Université de Montréal and welcomes over 4,000 students annually. For detailed information about accepted insurance plans, it is recommended to contact the hospital directly or visit their official website.
What awards or recognition has Maisonneuve-Rosemont Hospital received?
Maisonneuve-Rosemont Hospital, located in Montreal, Quebec, is renowned for its excellence in immunology-oncology, nephrology, and vision health. Its research center, CR-HMR, is globally recognized for pioneering clinical therapies and vibrant academic endeavors. The hospital leads in cellular therapy, innovating treatments for incurable diseases within its areas of excellence.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.